Rajita Pappu
Senior Scientist, Immunology Discovery
"The collaborative and science driven environment at Genentech is unparalleled. This enables us to identify and translate novel biological processes into potential therapeutics for the treatment of life-threatening diseases."
I joined Genentech in 2007 as a scientist in Immunology Discovery after finishing my postdoctoral training at UCSF where I studied the role of Sphingosine-1-phosphate in immunity and vascular development. I was drawn to Genentech because of the high caliber of science and the collaborative environment. These qualities foster creativity and teamwork that is integral to drug discovery.
Postdoctoral Mentor
The postdoctoral program at Genentech provides an excellent opportunity to do cutting-edge research and learn about drug discovery first-hand. The highly collaborative nature of research at Genentech allows postdocs to engage in cross-functional projects, enabling training that encompasses multiple scientific disciplines.
Featured Publication
Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone.
J Allergy Clin Immunol. 2017 Feb;139(2):705-708.e6.
